Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 242

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 242
---
have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”)
and have been consistently applied. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.
A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. The financial statements
of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. All significant
inter-company balances and transactions between the Company and its subsidiaries are eliminated upon consolidation.

The Company uses United States
Dollar (“$” or “US$”) as its reporting currency. The functional currency of the Company and Living Global is
US$, while Living HK is Hong Kong dollars (“HKD”), which is its local currency based on the criteria of ASC 830, “Foreign
Currency Matters”.

In the consolidated financial statements of
the Company, transactions in currencies other than the functional currencies are measured and recorded in the functional currencies using
the exchange rates in effect at the dates of the transactions. Assets and liabilities denominated in foreign currencies are translated
at year-end exchange rates, statements of income accounts are translated at average rates of exchange for the year and equity is translated
at historical exchange rates. All gains and losses arising from foreign currency transactions are recorded in the consolidated statements
of income and comprehensive income during the years in which they occur.

Translation of amounts from HKD into US$ has
been made at the following exchange rates:

|              |     | For the years ended 
               March 
                 31, |        |     |      |        |
|              |     |                2025 |        |     | 2024 |        |
| Average rate |     |                     | 7.7930 |     |      | 7.8246 |

|                    |     | As of March 31, |        |     |      |        |
|                    |     |            2025 |        |     | 2024 |        |
| Year-end spot rate |     |                 | 7.7799 |     |      | 7.8259 |

<div align='center'>F-8</div>

In preparing the consolidated financial statements
in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and
disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts
of revenues and expenses during the reporting year